Small cell lung carcinoma: Eight types of extension and spread on computed tomography

Journal of Computer Assisted Tomography

Volumn 30, Issue 4, 2006, Pages 653-661

  Kazawa, Nobukata ^a   Kitaichi, Masanori ^a   Hiraoka, Masahiro ^a   Togashi, Kaori ^a   Mio, Naoshi ^a   Mishima, Michiaki ^a   Wada, Hiromi ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Air space consolidation; Great vessel wall involvement; Lobar replaced extension; Lymphangitic spread; Peri bronchial extension; Peri intracardial extension; Pleural dissemination; Small cell carcinoma

Indexed keywords

CYTOLOGY; MULTIDETECTOR COMPUTED TOMOGRAPHY; RESPIRATORY SYSTEM;

AIR SPACE; AIR-SPACE CONSOLIDATION; CELL CARCINOMA; GREAT VESSEL WALL INVOLVEMENT; LOBAR REPLACED EXTENSION; LYMPHANGITIC SPREAD; PERI-BRONCHIAL EXTENSION; PERI/INTRACARDIAL EXTENSION; PLEURAL DISSEMINATION; SMALL CELL CARCINOMA; SMALL CELLS; VESSEL WALLS;

BIOLOGICAL ORGANS;

ADULT; ADVANCED CANCER; AGED; AORTA WALL; ARTICLE; BLOOD VESSEL WALL; BRONCHUS STENOSIS; CANCER CLASSIFICATION; CELL INFILTRATION; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; LUNG PARENCHYMA; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIDETECTOR COMPUTED TOMOGRAPHY; PLEURA EFFUSION; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY VEIN; SUPERIOR CAVA VEIN; THORAX WALL; TRACHEA STENOSIS;

EID: 33746257010     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004728-200607000-00017     Document Type: Article

References (25)

1. Simon GR, Wagner H. Small cell lung cancer. Chest. 2003;123 (Supplement 1):259-271.
2. JD Minna, Rosenberg, eds. Cancer: Principals and practice of oncology. VOL3JB Lippincott; 1989:591-705.
3. Colby TV, Koss MN, Travis WD. Carcinoma of the lung: Overview, incidence, etiology and screening. In: Atlas of Tumor Pathology. Tumors of the Lower Respiratory Tract. DC Washington: Armed Forces Institute of Pathology; 1995:91-106.
4. Pearlberg JL, Sandler MA, Lewis JW, et al. Small-cell bronchogenic carcinoma: CT Evaluation. AJR. 1988;150:265-268.
5. Whitley NO, Fuks JZ, McCrea ES, et al. Computed tomography of the chest in small cell lung cancer: potential new prognostic signs. AJR. 1984;141:885-892.
6. Norlund JD, Byhardt RW, Foley WD, et al. Computed tomography in the staging of small cell lung cancer: implications for combined modality therapy. Int J Rad Oncol Biol Phys. 1985; 11:1081-1084.
7. Bonner JA, Sloan JA, Shanahan TG, et al. Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small cell lung carcinoma. J Clin Oncol. 1999;17:681-2691.
8. Noda K, Nishiwaki Y, Kawahara M, et al. Randomized phase III study of irinotecan (CPT-11) and cisplatin versus etoposide and cisplatin in extensive disease small cell lung cancer: Japan Clinical Oncology Group study. Proc Am Soc Clin Oncol. 2000;19:483a.
9. Jung BC, Choong KP, Dong WP, et al. Does contrast enhancement on CT suggest tumor response for chemotherapy in small cell carcinoma of the lung? J Comput Assist Tomogr. 2002;26(5):797-800.
10. Mountain CF, Carr DT, Anderson WA. A new international staging system for lung cancer. Chest. 1986;89:225S-235S.
11. Mountain CF. Revisions in the international system for staging lung cancer. Chest. 1997;111:1710-1717.
12. Cymbalista M, Waysberg A, Zacharias C, et al. CT demonstration of the 1996 AJCC-UICC regional lymph node classification for lung cancer staging. Radiographics. 1999;19:899.
13. Munk PL, Muller NL, Miller RR, et al. Pulmonary lymphangitis carcinomatosis: CT and pathologic findings. Radiology. 1988;166:705-709.
14. Choe EH, Lee JH, Kim KH, et al. Obliteration of the pulmonary vein in lung cancer: Significance in assessing local extent with CT. J Comput Assist Tomogr. 1998;22:587-591.
15. Schneider J, Philipp M, Salewski L, et al. Pro-gastrin releasing peptide (ProGRP) and neuron specific enolase (NSE) in therapy control of patients with small cell lung cancer. Clin Lab. 2003;49:35-42.
16. Oremek GM, Sapoutzis N. Pro-gastrin releasing peptide (ProGRP), a tumor marker for small cell lung cancer. Anticancer Res. 2003; 23:895-898.
17. Cohen MH, Matthews ML. Small cell bronchogenic carcinoma: a distinct clinicopathologic entity. Semin Oncol. 1978;5:234-243.
18. Adler B, Padley S, Miller RR, et al. High resolution CT of bronchioalveolar carcinoma. Am J Roentogenol. 1992;159:275-277.
19. Wislez M, Cadranel J, Antoine M, et al. Lymphoma of pulmonary mucosa-associated lymphoid tissues: CT scan findings and pathological correlations. Eur J Respir. 1999;14:423-429.
20. Pignon JP, Arriagada R, Ihde DC, et al. A meta-analysis of thoracic radiotherapy for small cell lung cancer. N Engl J Med. 1992;327:1618-1624.
21. Shields TW, Higgins GA, Mathew MJ, et al. Surgical resection in the management of small cell carcinoma of the lung. J Thoracic Cardiovasc Surg. 1982;84:481-488.
22. Dales RE, Stark RM, Raman S. Computed tomography to stage lung cancer: approaching a controversy using meta-analysis. Am Rev Respir Dis. 1990;141:1096-1101.
23. Dwamena BA, Sonnad S, Angobaldo S, et al. Metastases from non-small cell lung cancer. Mediastinal staging in the 1990's: meta-analytic comparison of PET and CT. Radiology. 1999;213:530-536.
24. Martini N, Heelan R, Westcott J, et al. Comparative merits of conventional, computed tomographic, and magnetic resonance imaging in assessing mediastinal involvement in surgically confirmed lung carcinoma. J Thoracic Cardiovasc Surg. 1985;90:639-648.
25. Padovani B, Mouroux J, Seksik L, et al. Chest wall invasion by bronchogenic carcinoma: evaluation with MR imaging. Radiology. 1993;187:33-38.